文献速递腹部CT

不同骨骼肌指数界值定义的肌少症对失代偿期肝硬化长期死亡率的预测效能:一项前瞻性观察性研究

Predictive performance of distinct skeletal muscle index cut-offs-defined sarcopenia for long-term mortality in decompensated cirrhosis: A prospective observational study.
PubMed 文献 · Eur J Radiol · 2025-08-29

该前瞻性研究纳入478例因肝硬化相关急性损伤住院的患者,比较天津、中国北方、中国南方、日本和土耳其五种CT测量的骨骼肌指数界值定义的肌少症对2年全因死亡率的预测效能。结果显示五种标准诊断的肌少症患病率分别为24.3%、6.3%、21.1%、29.1%和6.5%,所有标准定义的肌少症组与非肌少症组生存率均有显著差异(log-rank检验P<0.05)。多因素Cox回归完全校正年龄、BMI和MELD-Na/CTP分级后,除土耳其标准外,其余标准定义的肌少症均与死亡率独立相关。作者认为研究结果支持制定基于洲际的骨骼肌指数界值,以识别肝硬化肌少症患者。

要点

  • 五种SMI界值定义的肌少症患病率差异明显,土耳其标准最低(6.5%),日本标准最高(29.1%)。
  • 所有标准定义的肌少症组与非肌少症组2年生存率均有显著差异(log-rank检验P<0.05)。
  • 完全校正年龄、BMI和MELD-Na/CTP分级后,除土耳其标准外,其余标准定义的肌少症均与死亡率独立相关。

核心结论

  • 五种SMI界值定义的肌少症均与失代偿期肝硬化患者2年全因死亡率相关,但土耳其标准在多因素模型中未显示独立关联;作者认为研究结果支持制定基于洲际的SMI界值以识别肝硬化肌少症患者。

研究设计与样本

  • 前瞻性观察性研究,纳入478例因肝硬化相关急性损伤住院的成人患者,采用CT测量的骨骼肌指数(SMI),以天津、中国北方、中国南方、日本和土耳其五种界值定义肌少症,参考标准为2年全因死亡率,采用Kaplan-Meier生存曲线和多因素Cox回归模型分析。

关键影像表现/征象

  • CT测量的骨骼肌指数(SMI)用于定义肌少症,不同界值标准下肌少症患病率分别为天津24.3%、中国北方6.3%、中国南方21.1%、日本29.1%、土耳其6.5%。

诊断标准与关键数值

  • 采用五种SMI界值标准(天津、中国北方、中国南方、日本、土耳其)定义肌少症;Kaplan-Meier生存分析显示所有标准定义的肌少症组与非肌少症组生存率均有显著差异(log-rank检验P<0.05);多因素Cox回归完全校正年龄、BMI和MELD-Na/CTP分级后,除土耳其标准外,其余标准定义的肌少症均与死亡率独立相关。

临床应用与阅片要点

  • 作者认为研究结果支持制定基于洲际的SMI界值,以识别肝硬化肌少症患者,并考虑其对死亡率和发病率的影响。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: Although the clinical implication of sarcopenia has been verified in the context of cirrhosis, there is limited data concerning cut-offs of CT-measured skeletal muscle index (SMI) across different ethnicities. We aimed to compare the predictive performance of distinct SMI values-defined sarcopenia for prognosis in cirrhosis.

METHODS: Totally, 478 inpatients due to cirrhosis-associated acute insults were prospectively enrolled. A range of cut-offs concerning SMI (Tianjin, northernChina, southernChina, Japan and Turkey criteria) were testified to determine 2-year all-cause mortality according to the Kaplan-Meier survival curve and multivariate Cox regression model.

RESULTS: Sarcopenia was diagnosed in 24.3 %, 6.3 %, 21.1 %, 29.1 % and 6.5 %, respectively, according to Tianjin, northernChina, southernChina, Japan and Turkey criteria. Survival analysis showed marked differences between patients with and without sarcopenia defined by all aforesaid criteria (log-rank test: P < 0.05). Univariate Cox regression indicated that age, Child-Turcotte-Pugh (CTP) class, Model for End-stage Liver Disease-Sodium (MELD-Na), creatinine, bilirubin, white blood cell count, prothrombin time-international normalized ratio, sodium, albumin, ascites, hepatic encephalopathy, infection and sarcopenia were significantly associated with mortality. Further multivariate model fully adjusting age, BMI and MELD-Na/CTP class revealed that all criteria-defined sarcopenia was independently associated with mortality, except for the Turkey criteria.

CONCLUSIONS: Our findings provide supporting evidence to develop continent-based SMI cut-offs in hopes of identifying sarcopenic patients with cirrhosis, taking its impact on mortality and morbidity into consideration.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Sun C, Wang H, Yang Z, et al. Predictive performance of distinct skeletal muscle index cut-offs-defined sarcopenia for long-term mortality in decompensated cirrhosis: A prospective observational study. Eur J Radiol. 2025. PMID: 40902438. doi:10.1016/j.ejrad.2025.112396

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。